ACIU
AC Immune SA
Company Overview
| Mkt Cap | $353.44M | Price | $3.38 |
| Volume | 411.70K | Change | +0.00% |
| P/E Ratio | -6.9 | Open | $3.44 |
| Revenue | $27.3M | Prev Close | $3.38 |
| Net Income | $-50.9M | 52W Range | $1.43 - $4.00 |
| Div Yield | N/A | Target | $9.00 |
| Overall | 55 | Value | -- |
| Quality | 36 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyAC Immune SA (ACIU) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.38 with a market capitalization of $353.44 million. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 36.
Today's trading session shows ACIU with a volume of 412K shares. The stock opened up 1.78% from yesterday's close of $3.38. Current analyst estimates project earnings of $-0.91 per share for this year, with next year targeting $-0.75.
ACIU demonstrates strong technical indicators based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ACIU include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 166.3%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:12 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACIU | $3.38 | 0% | 411.70K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |